In the stage III CRC, a high ACP2 expression without chemotherapy (n = 10) also had the worst survival (P = 0.044; Supplementary Figure 2), confirming that high ACP2 expression was an unfavorable prognostic factor. The gene discussed is ACP2; the disease is colorectal carcinoma.